Drug factory · FDA FEI 3021389808
Teyro Labs Private Limited
Plot No. A-9/1, SIPCOT Industrial Growth Centre Oragadam, Kanchipuram District, India
Problems found, fixed voluntarily at FDA's last inspection, Nov 12, 2025.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
1 drug inspection on record since 2025: 0 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Capecitabine | Makes it, tests it and packages it | Teyro Labs Private Limited | 82511-001, 82511-002 |
| Carboplatin | Makes it, tests it and packages it | Apotex Corp., Natco Pharma USA LLC, Teyro Labs Private Limited | 60505-6282, 69339-364, 69339-365 +6 |
| Gemcitabine | Makes it, tests it and packages it | Teyro Labs Private Limited | 82511-008, 82511-009 |
| Pazopanib | Makes it | Novugen Pharma (USA) LLC. | 82293-022 |
| Sunitinib | Makes it | Novugen Pharma (USA) LLC. | 82293-014, 82293-015, 82293-016 +1 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Nov 12, 2025 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; manufacture; pack.